看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。/ u0 z$ o3 X* o8 t) u; ^; u
3 x* Q- r6 @7 O$ F
& h* ?( s5 [; FCurrently available feasibility data for possible combination strategies.
" e- ]+ {0 Z0 }————————————————————————————————
" j5 r: H X/ sCombination Feasibility according to preliminary data
5 [! ]0 V; X P& i——————————————————————————————————
( l& h7 K2 ?/ {Bevacizumab + sorafenib Yes, reduced dose 7 z a8 d2 Z+ a* _' s( ?) `+ O
Bevacizumab + sunitinib† No
$ t' L8 N2 e. N) p* w+ |Bevacizumab + temsirolimus Yes
4 l I3 t$ R6 J0 Y8 qBevacizumab + everolimus Yes
+ x" t1 I9 M# {1 C( S/ _Sorafenib + sunitinib ? , a C# Z* K6 I4 K9 ~( k
Sorafenib + temsirolimus Yes, reduced dose
9 Q: q# E( I* [2 ?# H QSorafenib + everolimus Yes, reduced dose
0 g# t: Z: g t( P1 ~% ^0 K; \$ c% j4 F2 BSunitinib + temsirolimus† No , Y: m k5 F; ]$ q+ G5 W
Sunitinib + everolimus ?
$ J2 r4 @' a9 O% Y( C9 l. R" GTemsirolimus + everolimus ? 0 [- V( E3 n9 J: M- D# S
————————————————————# u% P3 h: E0 B, X9 p5 F
†Led to US FDA warning.
0 G( V9 }( k- |?: As yet unattempted combination.2 W! {' ]. E5 [" d B
|